Provided by Tiger Trade Technology Pte. Ltd.

Septerna, Inc.

40.00
-0.7900-1.94%
Post-market: 40.000.00000.00%19:30 EDT
Volume:289.81K
Turnover:11.73M
Market Cap:1.87B
PE:-73.74
High:41.44
Open:41.44
Low:39.95
Close:40.79
52wk High:51.10
52wk Low:11.70
Shares:46.68M
Float Shares:22.90M
Volume Ratio:0.66
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5424
EPS(LYR):-1.1044
ROE:-6.34%
ROA:-7.13%
PB:4.83
PE(LYR):-36.22

Loading ...

Septerna is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 20

Septerna price target raised to $48 from $38 at JPMorgan

TIPRANKS
·
Aug 19

U.S. Research Roundup-Cogent Communications, Dollar Tree, Home Depot

Reuters
·
Aug 19

Septerna, Inc. (SEPN) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Aug 17

Truist Financial Reaffirms Their Buy Rating on Septerna, Inc. (SEPN)

TIPRANKS
·
Aug 14

Septerna President, COO Elizabeth Bhatt Sells 25,000 Shares Worth $1.1 Million Under 10b5-1 Plan

Reuters
·
Aug 14

Does Septerna (SEPN) Pair Narrowing Losses With A Cash Runway That Truly Supports Its Pipeline Strategy?

Simply Wall St.
·
Aug 13

Septerna, Inc. : Wells Fargo Raises Target Price to $50 from $48

THOMSON REUTERS
·
Aug 12

Wall Street Analysts Are Bullish on Top NA Picks

TIPRANKS
·
Aug 12

Septerna is Maintained at Buy by Guggenheim

Dow Jones
·
Aug 11

Septerna price target raised to $49 from $45 at Raymond James

TIPRANKS
·
Aug 11

C4 Therapeutics Q2 Revenue Beats Estimates, Helped by Roche Collaboration

Reuters
·
Aug 11

Septerna Q2 Loss Narrows, Revenue Rises

MT Newswires Live
·
Aug 11

Septerna, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Earnings Flash (SEPN) Septerna Posts Q2 Loss Per Share $0.29, vs. FactSet Est of $0.43 Loss

MT Newswires Live
·
Aug 11

Septerna Q2 Revenue Beats Analyst Estimates, Driven by Novo Nordisk Partnership

Reuters
·
Aug 11

Septerna Q2 EPS $(0.29) Beats $(0.43) Estimate, Sales $26.746M Beat $17.875M Estimate

Benzinga Earnings
·
Aug 11

Press Release: Septerna Highlights Business Progress and Reports Second Quarter 2026 Financial Results

Dow Jones
·
Aug 11

Septerna SVP Drug Discovery Daniel D. Long Sells USD 114,901.29 in Common Shares

Reuters
·
Aug 06

3 Small-Cap Stocks Analysts Expect to Rally Big

TIPRANKS
·
Aug 04